chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had one friend in his early 50s, healthy until he got the first shot, 2 strokes since; Initial information was received on 23-Sep-2023 regarding an unsolicited valid Social Media serious case received from a consumer/non-health-care professional.  This case involves an unknown age male patient who had one friend in his early 50s, healthy until he got the first shot, 2 strokes since after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a unknown dose of suspect influenza vaccine produced by unknown manufacturer (lot number, expiry date, strength, formulation not reported) via unknown route in unknown administration site for prophylactic vaccination(Immunization). The information on batch number was requested.  On an unknown date the patient developed had one friend in his early 50s, healthy until he got the first shot, 2 strokes since (cerebrovascular accident) (unknown latency) following the administration of influenza vaccine.    It is unknown if there were lab data/results available.   Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event (had one friend in his early 50s, healthy until he got the first shot, 2 strokes since).  At time of reporting, the outcome was Unknown for the event had one friend in his early 50s, healthy until he got the first shot, 2 strokes since.  Seriousness Criteria : This event was assessed as medically significant.; Sender's Comments: Sanofi Company Comment dated 28-Sep-2023 : This case involves an unknown age male patient who had one friend in his early 50s, healthy until he got the first shot, 2 strokes since after receiving vaccine influenza vaccine. Further information regarding Past medical history, concurrent condition, concomitant medication and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported events are needed to fully assess this case. Based upon the reported information, the role of a vaccine cannot be assessed.
a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; a large red circle around the injection site,larger than a grapefruit. Itching, redness, swelling,warm to the touch, painful to walk.; Initial information received on 10-Feb-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 years old female patient who had a large red circle around the injection site,larger than a grapefruit. itching, redness, swelling,warm to the touch, painful to walk after receiving vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL].  The patient had no past medical history, concomitant medication. The patient medical treatment(s),  vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE Solution for injection in pre-filled syringe (strength was unknown, lot number: U7526AA and expiry date was unknown) via intramuscular route in the right thigh for prophylactic vaccination.  On 10-Feb-2023 the patient developed a non-serious event of a large red circle around the injection site,larger than a grapefruit. itching, redness, swelling,warm to the touch, painful to walk. (pain, vaccination site pruritus, vaccination site erythema, vaccination site swelling, vaccination site warmth and vaccination site pain) (unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE.  Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE (QUADRACEL) was not applicable.  It was not reported if the patient received a corrective treatment for the events.   Outcome: Not Recovered / Not Resolved for all events.
pt sits on exam table - gave MENACTRA im to LD then HPV im RD. A few second later patient feels dizzy and passed out and lying on exam table, for about one minute then awake and talking but feeling tired. Apply O2 P = 64 BP = 100/64 observe 15 mn then discharge home in a good condition fully awake.
received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR180389:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180391:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180388:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180387:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180386:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180385:Original Case : US2021179651 US-GLAXOSMITHKLINE-US2021AMR180390:Original Case : US2021179651
Right after the dosis, around 4 hours after, I started to feel nauseous and dizzy. I returned home, took a shower, and soon started coughing and a very high fever, followed by chills. I had between 38 and 38.7 C of fever until 9 AM the other day. I felt pain all over my body in a very different way, not like the flu. On Saturday, the day after the vaccine, I had low blood pressure and a complete loss of appetite. On Sunday, I had no symptoms.
IN THE ARM WHERE THE VACCINE WAS PLACED ME  ( RED RASH AND ITCHY) 01 -26 -2021 IN VARIOUS PARTS OF THE BODY  (RED RASH AND ITCHY )  02 29-2021
dizziness, Light-headed; I feel like when I walk for sometime or when I stand up I feel that I have to sit and I am feeling that things are moving; Sleeplessness; This is a spontaneous report from a contactable consumer (patient). A 32-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EW0183 and expiration date was not reported), dose 2 via an intramuscular route of administration, administered in arm right on 13Jun2021 at 16:00 (last Sunday) as 2nd dose, single (age at vaccination was 32 years) for COVID-19 immunization. No medical history and concomitant medications were reported. Previously patient received of bnt162b2 first dose (lot number was EW0178 and expiration date was not reported) for COVID-19 immunization on 25May2021. The other vaccines were not reported. The patient experienced dizziness, light-headed, "I feel like when I walk for sometime or when I stand up I feel that I have to sit and I am feeling that things are moving", and sleeplessness on an unspecified date. The clinical course of the narrative was reported as: the patient had taken this Pfizer COVID 19 BioNTech vaccine last Sunday, it was good done Sunday, Monday, and Tuesday from Wednesday, the patient started feeling dizziness, little dizziness, the patient thought it was due to sleeplessness and something so patient managed Wednesday and it was there yesterday and it was, the patient still feeling it today (as reported) as well. So, patient felt like when patient walk for sometime or when patient stand up and felt that patient had to sit and patient was feeling that things were moving and this kind of things patient could say light headed or something. The patient said that already had asked for a PCP (primary care physician since 01May and it had been one and half month now and there had not been anyone assigned to her. The patient inquired ant tablet or pill that patient should had it. The patient wanted to take some support either a wall or any nearby feeling those kind of and patient had verified CO2 percentage and the BP (blood pressure) those were all normal but not sure why patient was feeling dizziness. The events persisting, patient mean from these four days only the earlier days were no such symptoms happening. Reporter seriousness for the events was reported as unspecified. The outcome of the events was not resolved.  Follow-up attempts are possible. Further information is expected.
noticed small red rash on lt forearm (same arm injected); rash was warm to touch & itchy; the rash cleared 8 or 9 hrs later; pt had a low grade fever of 100.6 on day 2 & 99.6 on day 3 & felt tired but fine;
Patient was hospitalized on 8/22/21 stating that she could not breath and passed away. Her second COVID vaccine was received on 8/19/2021.
RASH  AROUND THE BELLY AND ON THE BREAST/A LOT OF RASH ON HER BACK; FEVER; HEADACHES; DIFFICULTY SWALLOWING; NOT ABLE TO EAT; ITCHING UNDER THE BREAST; RIGHT ARM IS SORE AT  THE INJECTION SITE AND IT FEELS HARD; This spontaneous report received from a patient concerned a 28 year old female. The patient's height, and weight were not reported. The patient's past medical history included: anemia, and concurrent conditions included: no alcohol use, and non smoker, and other pre-existing medical conditions included: The patient had no known allergies, and no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, and expiry: UNKNOWN) dose was not reported, administered on 06-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On AUG-2021, the patient experienced right arm is sore at the injection site and it feels hard. On 06-AUG-2021, the patient experienced difficulty swallowing. On 06-AUG-2021, the patient experienced not able to eat. On 06-AUG-2021, the patient experienced itching under the breast. On 06-AUG-2021, the patient experienced fever. On 06-AUG-2021, the patient experienced headaches. On 07-AUG-2021, the patient experienced rash around the belly and on the breast/a lot of rash on her back. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash around the belly and on the breast/a lot of rash on her back, and the outcome of fever, difficulty swallowing, headaches, not able to eat, itching under the breast and right arm is sore at the injection site and it feels hard was not reported. This report was non-serious.
No additional AE reported; Caller is a medical assistant calling to report that an expired dose of ROTATEQ was administered to the patient on 23SEP2022.; This spontaneous report has been received from a medical assistant concerning to a patient of an unknow age and gender. The patient's medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 23-SEP-2022, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, by defaulted oral route of administration, at a dose of 2 milliliter (ml) (strength and vaccination scheme frequency were not provided; lot number 1742462 that was verified to be a valid lot number with an expiration date reported as and established as 19-SEP-2022) (expired product administered) for prophylaxis.  By the reporting time, the caller confirmed that the dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not involved in a temperature excursion prior to the date of administration.  No additional adverse event (AE) was reported (no adverse event).
Patient of 16 years old received 2 doses of the Moderna COVID19  vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient of 16 years old received 2 doses of the Moderna COVID19  vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient of 16 years old received 2 doses of the Moderna COVID19  vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient of 16 years old received 2 doses of the Moderna COVID19  vaccine) had resolved.            No concomitant medication was provided. No treatment medication was provided.   This case was linked to MOD-2021-428400 (Patient Link).
Admitted to hospital on 2/22 with RLL pneumonia on day 20 of COVID infection after receiving three doses of the vaccine.
This spontaneous report was received from 60-year-old female patient who was also a healthcare worker, via a company representative, who was referring on herself. On an unknown date, the patient was vaccinated with ZOSTAVAX for prophylaxis. Other suspect therapies included sterile diluent (STERILE DILUENT). On an unknown date (reported as "about 10 days later"), the patient experienced injection site mass, injection site erythema, injection site pain and injection site pruritus. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
At the time of my vaccine I told them about my allergies and waited the 15 minutes afterwards, and I was fine and leaving the place and on my way home talking to my husband on the phone when all of a sudden I noticed I couldn't swallow and so I went straight to the ER. My tongue was feeling funny and I told them I could still breathe but I was having trouble swallowing and my tongue was tingling. They took me back and gave me Benadryl and Raglan. I felt fine after the Benadryl and went home and 1-2 days later I noticed a pain behind my left ear and went to the ER again and had swelling and inflammation there. The ER doctor it had something to do with my lymph nodes and it was very ride. I was itching so bad and he said my histamine levels were high. At this point, I had been to urgent care and ER many times. I was going because of chest discomfort that wouldn't ease up and they said I was having precordial pain and I ended up having to have a echocardiogram 4-5 days after vaccine. A few weeks later I had another test that showed I had fluid and stuff. They're going to check this time because it showed twice already I had fluid by my heart around pericardia. I've had to take hydroxyzine and other medications. It took some time but the itching has gotten way better because at first it was off the charts and felt like it was inside my body. All of this didn't happen until after the vaccine and it happened for months before it was controlled. I still have chest discomfort which I push to the side because of my gastritis but with my medication my chest discomfort subsides. I have a cardiac MRI on 01/26/22.
Shoulder pain and loss of range of motion in the arm (left) that received vaccination. Tingling in the forearm and hand. Also have clicking in the shoulder. It feels like it wants to come out of joint. It is worthy to note that the vaccine administer was standing (as I was seated) on my right side and reached over me and with one hand and gave me the injection near the top of my left shoulder.
Reacted to all 3 doses of the vaccine. For all doses had swollen glands. Dose 1: swollen glands, slight fever, frequent headaches, glands were under chin area and beneath the tongue. Sensation of golf ball underneath throat, did not see the doctor, just waited it out. Dose 2: Similar symptoms to dose 1, except experienced chills, temperature was stable. Dose 3: Swollen glands were underneath the ears in the back like two hard peas, immediately after the dose, the swelling has not gone down. 2 weeks before 11/4 experienced sharp shooting pain behind the ear, felt like unbearable nerve pain, lightning bolts. The pain did not subside, so went to urgent care on recommendation of a consulting nurse. At urgent care, did ultrasound on the neck, and felt that lymph nodes in the neck were swollen (not just under the chin), under the armpits, near the groin. Advised to apply heat on the neck, not given any medication. Then went to lymphatic massage therapist a week later (week before 11/4). Did a massage to try and soothe some of the lymphnode pain, as the nodes were pushing on the nerves causing pain. The entire lymphatic system was swollen overall. Still having some neck pain and swelling.
This spontaneous report was received from a medical assistant, referring to a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with an incorrect stored dose of PROQUAD lot # N014947 with expiration date on 11-SEP-2018 (strength and route were not reported) for prophylaxis, however no adverse effects reported. Other suspect therapies included VARIVAX and sterile diluent. 2018 (strength and route were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 30 Fahrenheit grades range for a time frame of 4 hours and 40 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1709USA005671.
nauseous/ queasy/ Terribly nauseous; tired/ fatigue; slept right through the night; This is a spontaneous report from a contactable consumer or other non hcp. A 82-year-old female patient received bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration on 31Jan2021 as SINGLE DOSE for covid-19 immunisation. Medical history included diabetes mellitus from an unknown date and unknown if ongoing Verbatim: Diabetic, thyroid disorder from an unknown date and unknown if ongoing Thyroid medication. Concomitant medication included levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported; (OCUVITE) taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient experienced nauseous/ queasy/ terribly nauseous, tired/ fatigue, slept right through the night. The patient underwent lab tests and procedures which included weight fluctuation: 112, 110, 111 on It's about 112 pounds, once day it's 110, 111 it depends on (incomprehensible word). The action taken in response to the event for bnt162b2 was not applicable. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
In between my first and second dose I noticed that my left arm was a little swollen.  I asked the nurse before I got my second dose if that was normal and she advised it should go away.  After my second dose.  My arm swelling got worse and by October my swelling was quite large and my arm was very heavy and I was in a lot of pain.  My primary doctor could tell there was a mass of some sort and sent me for an ultrasound but it was inconclusive.  My dermatologist did a biopsy and pretty much inconclusive. I have seen an Allergist, Rheumatologist, Oncologist, Orthopedist and  My Neurologist did an MRI and still no answers.  Getting ready to start some physical therapy to see if I can get movement back in my arm without pain.  My arm hurts to raise or twist or turn.  Still swollen after almost a year.
This spontaneous report was received from the medical assistant refers to a 4 year old female patient. The patient's concurrent conditions, medical history, drug reactions and allergies were not reported. Concomitant therapies administered to the patient included sterile diluent (MRK) used to reconstitute the PROQUAD was properly stored. On 07-JUN-2018, the patient was vaccinated with improperly stored doses of PROQUAD recombinant Human albumin (rHA) (lot number R001541, expiration date 15-JUL-2019), subcutaneously. The doses of PROQUAD were exposed to a temperature excursion of 6 degrees Fahrenheit (°F) to 14°F (also reported as "9F") for a time frame of 10 minutes; and of 15°F to 46°F (also reported as "25F") for 20 minutes. The temperature excursion was not detected by the Digital Data Logger. There was no previous temperature excursion either. No adverse effects or product quality complaints were reported. This is one of the multiple reports received from the same reporter. Sender's Comments: US-009507513-1806USA001756.
Fever of 99.4, roof of mouth burning, headache, lips slightly swollen, and it comes and goes. Patient states he doesn't feel like he has a fever right now.
vaccine administered 4/8 at 1429 patient had a cardiac arrest on 4/8 at 2209 patient expired 4/10/21
Within hours of receiving the Covid-19 second booster injection the resident was not able to stand or ambulate. This immobility continued about 48 hours and then she became able to ambulate but only with strong assistance. Before the Covid injection she was fully ambulatory, used a rollator and rarely stumbled. She is now wheelchair bount and often falls from attempts to stand on her own.
4 hours after the vaccines, patient started screaming crying - a cry I've never heard before. It was piercing and she was inconsolable for over two hours. Until she finally fell asleep from crying so hard. She's never carried like that and has yet to cry like that again. All clear signs of encephalitis.
This spontaneous report as received from a registered pharmacist via a company representative refers to an unknown number of patients of unknown age and gender. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX23 (lot # not reported) dose and route not reported. No concomitant medications were reported. The representative reported that pharmacist told her that there had been a couple of reactions with vaccinations of PNEUMOVAX23. The representative had no information about the reactions with PNEUMOVAX23 at the time of the call. The outcome of the event was unknown at the time of this report. No other information to report. Additional information has been requested.